Viewing Study NCT05184803


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2025-12-25 @ 5:20 PM
Study NCT ID: NCT05184803
Status: RECRUITING
Last Update Posted: 2024-02-28
First Post: 2021-12-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
Sponsor: Asan Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module